---
title: "FDC Ltd (FDC) — Share Price, Financials & Analysis"
symbol: "FDC"
company: "FDC Ltd"
canonical: "https://tapetide.com/stocks/FDC"
isin: "INE258B01022"
nse_symbol: "FDC"
bse_code: "531599"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 5530.66
generated_at: "2026-09-13T18:45:00.612Z"
---

# FDC Ltd (FDC)

Canonical page: https://tapetide.com/stocks/FDC

## Company

- **NSE Symbol:** FDC
- **BSE Code:** 531599
- **ISIN:** INE258B01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1997-08-07
- **CEO:** Dr. Nandan Mohan Chandavarkar
- **Employees:** 6857
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** fdcindia.com

## About

FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Some of FDC’s leading brands in India include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zathrin, Zipod, Cotaryl and Mycoderm in the domestic and international markets.[1]

## Latest Price

- **Price:** ₹341.45
- **Change:** -3.9 (-1.13%)
- **Open:** ₹344
- **Day High:** ₹344.8
- **Day Low:** ₹339
- **Previous Close:** ₹345.35
- **Volume:** 136483
- **As Of:** 2026-09-11T10:20:48+00:00

## Key Fundamentals

Observed at 2026-09-11T04:36:13.054359Z.

- **Market Cap:** ₹5530.66 Cr
- **Classification:** Microcap
- **P/E (reported):** 19.2
- **P/E (TTM):** 19
- **EPS (TTM):** ₹17.97
- **EPS (reported):** ₹19.31
- **Book Value:** ₹152.64
- **Price to Book:** 2.26
- **Dividend Yield:** 1.45%
- **ROE:** 11.32%
- **ROCE:** 14.86%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹2284.5 Cr
- **Net Income:** ₹281.4 Cr
- **EBITDA:** ₹459.6 Cr
- **52-Week High:** ₹527.8
- **52-Week Low:** ₹312.95
- **RSI (14):** 41.28

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 73.67 | 9% |
| growth | 20.33 | 9% |
| momentum | 23.98 | 12% |
| ownership | 35.86 | 24% |
| quality | 43.47 | 22% |
| valuation | 79.73 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.8%

### Weaknesses

- The company has delivered a poor sales growth of 10.3% over past five years.
- Company has a low return on equity of 12.3% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -36.88% | -9.2% | 24% |
| ebitda margin growth | 22.01% | 6.51% | -6.55% | -2.14% |
| net income growth | 28.14% | 5.47% | 12% | -1% |
| revenue growth | 12.71% | 3.9% | 7% | 10% |
| roce | 23.69% | -3.38% | -19.89% | 15.26% |
| roe | 28.13% | -3.25% | 12.52% | 2.44% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 486 | 458 | 462 | 638 | 514 | 464 | 492 | 648 | 473 | 465 | 585 | 668 |
| Expenses | 410 | 374 | 406 | 492 | 444 | 417 | 438 | 508 | 439 | 412 | 478 | 525 |
| Operating Profit | 76 | 84 | 56 | 147 | 70 | 47 | 54 | 140 | 34 | 52 | 106 | 143 |
| OPM % | 16 | 18 | 12 | 23 | 14 | 10 | 11 | 22 | 7 | 11 | 18 | 21 |
| Other Income | 27 | 25 | 20 | 28 | 35 | 19 | 16 | 36 | 21 | 0 | 50 | 48 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 10 | 10 | 10 | 11 | 14 | 13 | 16 | 15 | 15 | 15 | 14 | 15 |
| Profit before tax | 93 | 98 | 65 | 163 | 90 | 51 | 53 | 160 | 38 | 36 | 140 | 175 |
| Tax % | 25 | 19 | 29 | 27 | 20 | 28 | 27 | 24 | 26 | 22 | 26 | 24 |
| Net Profit | 70 | 79 | 46 | 119 | 72 | 37 | 39 | 121 | 28 | 28 | 103 | 132 |
| EPS in Rs | 4.29 | 4.87 | 2.84 | 7.31 | 4.42 | 2.28 | 2.38 | 7.45 | 1.74 | 1.74 | 6.35 | 8.14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1074 | 1089 | 1341 | 1331 | 1525 | 1784 | 1943 | 2108 | 2171 | 2190 |
| Expenses | 841 | 860 | 1038 | 997 | 1271 | 1533 | 1604 | 1783 | 1825 | 1855 |
| Operating Profit | 233 | 229 | 304 | 334 | 254 | 251 | 339 | 325 | 346 | 335 |
| OPM % | 22 | 21 | 23 | 25 | 17 | 14 | 17 | 15 | 16 | 15 |
| Other Income | 45 | 42 | 57 | 95 | 76 | 50 | 102 | 91 | 93 | 118 |
| Interest | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 5 |
| Depreciation | 35 | 33 | 37 | 38 | 37 | 39 | 40 | 54 | 59 | 59 |
| Profit before tax | 241 | 237 | 320 | 388 | 289 | 258 | 396 | 357 | 375 | 390 |
| Tax % | 28 | 28 | 25 | 22 | 25 | 25 | 23 | 25 | 25 | — |
| Net Profit | 174 | 170 | 240 | 301 | 216 | 194 | 305 | 267 | 281 | 293 |
| EPS in Rs | 9.95 | 9.74 | 14.03 | 17.85 | 12.82 | 11.7 | 18.75 | 16.39 | 17.29 | 17.97 |
| Dividend Payout % | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 31 | 29 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 16 | 16 | 16 |
| Reserves | 1252 | 1259 | 1428 | 1530 | 1717 | 1940 | 1965 | 2081 | 2265 | 2469 |
| Borrowings | 1 | 1 | 1 | 15 | 15 | 32 | 28 | 21 | 21 | 15 |
| Other Liabilities | 197 | 228 | 194 | 250 | 208 | 281 | 333 | 350 | 412 | 418 |
| Total Liabilities | 1468 | 1505 | 1640 | 1813 | 1956 | 2270 | 2343 | 2468 | 2714 | 2919 |
| Fixed Assets | 678 | 674 | 682 | 674 | 689 | 705 | 699 | 680 | 852 | 999 |
| CWIP | 6 | 13 | 12 | 24 | 19 | 105 | 198 | 261 | 137 | 96 |
| Investments | 491 | 471 | 585 | 665 | 790 | 886 | 806 | 843 | 1028 | 1048 |
| Other Assets | 293 | 348 | 360 | 451 | 458 | 575 | 640 | 684 | 698 | 775 |
| Total Assets | 1468 | 1505 | 1640 | 1813 | 1956 | 2270 | 2343 | 2468 | 2714 | 2919 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 154 | 150 | 112 | 250 | 207 | 162 | 155 | 221 | 318 | 200 |
| Cash from Investing Activity | -144 | 21 | -121 | -98 | -77 | -145 | 11 | -17 | -199 | -110 |
| Cash from Financing Activity | 0 | -169 | 0 | -142 | -129 | -10 | -180 | -202 | -92 | -93 |
| Net Cash Flow | 11 | 1 | -8 | 10 | 1 | 7 | -14 | 2 | 26 | -3 |
| Free Cash Flow | 130 | 114 | 70 | 247 | 148 | 35 | 47 | 151 | 227 | 40 |
| CFO/OP | 92 | 94 | 81 | 110 | 90 | 95 | 93 | 96 | 129 | 83 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 27 | 28 | 29 | 34 | 30 | 20 | 25 | 22 | 19 | 26 |
| Inventory Days | 148 | 166 | 184 | 180 | 189 | 210 | 183 | 216 | 186 | 182 |
| Days Payable | 81 | 101 | 82 | 101 | 68 | 94 | 99 | 103 | 102 | 106 |
| Cash Conversion Cycle | 94 | 93 | 131 | 113 | 152 | 135 | 109 | 135 | 103 | 102 |
| Working Capital Days | 23 | 29 | 45 | 40 | 48 | 45 | 48 | 53 | 33 | 41 |
| ROCE % | 21 | 19 | 17 | 21 | 22 | 15 | 13 | 18 | 16 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% |
| FIIs | 2.42% | 2.43% | 2.65% | 2.51% | 2.62% | 2.67% | 2.55% | 2.41% | 2.43% | 2.32% | 2.4% | 1.4% |
| DIIs | 8% | 7.61% | 6.94% | 6.73% | 6.03% | 6.08% | 6.37% | 7.17% | 6.82% | 6.27% | 6.29% | 6.31% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 15.94% | 16.12% | 16.54% | 16.71% | 16.7% | 16.57% | 16.22% | 16.17% | 16.4% | 16.97% | 16.82% | 17.64% |
| Others | 3.98% | 4.18% | 4.22% | 4.39% | 5% | 5.02% | 5.2% | 4.59% | 4.7% | 4.78% | 4.83% | 4.99% |
| No. of Shareholders | 56928 | 55341 | 52377 | 50634 | 55400 | 55228 | 53880 | 54445 | 54157 | 53788 | 52730 | 55045 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 342.5 | Sell |
| EMA (10) | 344.75 | Sell |
| SMA (20) | 344.79 | Sell |
| EMA (20) | 349.65 | Sell |
| SMA (50) | 379.8 | Sell |
| EMA (50) | 366.57 | Sell |
| SMA (100) | 382.98 | Sell |
| EMA (100) | 376.34 | Sell |
| SMA (200) | 382.02 | Sell |
| EMA (200) | 387.74 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 38.7 | Neutral |
| MACD (12,26,9) | -8.6 | Buy |
| Stochastic (14,3,3) | 65.24 | Neutral |
| ADX (14) | 37.15 | Buy |
| Williams %R (14) | -54.74 | Neutral |
| ATR (14) | 10.32 | High Volatility |
| ROC (12) | -1.67 | Sell |
| Stoch RSI (14) | 60.22 | Neutral |
| UO (7,14,28) | 43.33 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=567dc302-8ddc-4ad3-b35c-4c2077f71944.pdf) |
| 2026-09-03 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=BD9FDD4B_4B1F_4281_807F_DDE9DCC7FE5A_093140.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79623e6c-2cd7-4794-8824-b80963f46563.pdf) |
| 2026-09-01 | [Notice Of 86Th Annual General Meeting For The FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79d01138-29bc-42f1-b660-f0bc205f3b11.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2964112c-e4f5-4174-8e3f-e034f77cc200.pdf) |
| 2026-09-01 | [Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f931e5a-df18-46dc-bea1-19c83d052ca2.pdf) |
| 2026-09-01 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c5f6a2b-b840-4a84-88b2-49a2dcf30cef.pdf) |
| 2026-08-27 | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fd37717-6fd3-4fcf-bff4-d845b134560e.pdf) |
| 2026-08-13 | [Grant Of Marketing Authorisation From MHRA UK For Atropine 1.0% W/V Eye Drops Solution.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bb96f9-3858-4bf4-98b8-846dfd738e41.pdf) |
| 2026-08-05 | [Board Meeting Outcome for Board Meeting Outcome For Outcome For The Board Meeting Held On August 05 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0506c1eb-be2b-474f-bf4d-ae1d6cb225f1.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-05 | [Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cd01a3f-5cbb-4b4e-a867-efd1b13c3386.pdf) |
| 2026-05-27 | [Standalone And Consolidated Financial Results For Financial Year Ending March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=162e10d1-a3bf-4363-bae2-ab714281427b.pdf) |
| 2025-05-28 | [Results-Financial Results For March 312025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b134b8c-c546-42a5-a1e7-28ad58565adc.pdf) |
| 2025-02-12 | [Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9592e6a3-9b85-4535-be42-6b676330bba5.pdf) |
| 2024-11-06 | [Unaudited ( Standalone And Consolidated) Financial Results For Quarter And Half Year Ended On September 30,2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecfd8bf5-e78c-4aa9-a010-affab410bbc5.pdf) |
| 2024-08-07 | [Quarterly Financial Results For The Period Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a297501-4f15-42d1-b234-225a13f498f1.pdf) |
| 2024-05-29 | [Outcome Of Board Meeting May 29, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ba14ef6-5fa1-44e0-95c3-ed48437e9b18.pdf) |
| 2024-02-07 | [Unaudited Financial Results For The Period Ended December 31, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5af0f47-2755-4a8a-93ba-73f8b7e478fe.pdf) |
| 2023-11-08 | [Unaudited Financial Results For The Half Year Ended September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=047cbb94-4bb7-42cd-9aed-1a229dd76059.pdf) |
| 2023-08-09 | [Quarterly Financial Results For The Period Ended June 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0779fff1-b9b4-46c5-a801-ca7d1a21e612.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 2d - FDC corrigendum changes director appointment resolution to special resolution. | [Corrigendum To Postal Ballot Notice Dated April 21, 2026 2d - FDC corrigendum changes director appointment resolution to special resolution.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e3f56b19-ccf4-4233-94e1-2f55278a0094.pdf) |
| 26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited FY2026 results; board date pending. | [Closure of Trading Window 26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited FY2026 results; board date pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95de0c32-1d74-4bf3-987a-18ae21cc720b.pdf) |
| 24 Apr - FDC confirms it is not a large corporate; outstanding borrowings were nil as of March 31, 2026. | [Confirmation Regarding Company Not Falling Under Large Corporate Criteria As On March 31, 2026 24 Apr - FDC confirms it is not a large corporate; outstanding borrowings were nil as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/65a24b1e-81b4-4461-ba61-933b2d54846a.pdf) |
| 24 Apr - Copies of Newspaper advertisement regarding the Notice of Postal Ballot. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Apr - Copies of Newspaper advertisement regarding the Notice of Postal Ballot.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5c0bad68-8ca4-4327-a45a-b9f117874dd5.pdf) |
| 21 Apr - Board seeks postal ballot approval for Kishore Saletore’s 5-year appointment from April 1, 2026. | [Announcement Under Regulation 30 - Postal Ballot 21 Apr - Board seeks postal ballot approval for Kishore Saletore’s 5-year appointment from April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4f9793e-9a46-4852-aec6-ee68b4880ae2.pdf) |
| 20 Mar - Board committees reconstituted; Mohan Chandavarkar re-designated Chairman & Managing Director effective 1 April 2026. | [General Update 20 Mar - Board committees reconstituted; Mohan Chandavarkar re-designated Chairman & Managing Director effective 1 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ad84f5e4-9b35-4e3f-ade4-55a2c36d938b.pdf) |
| 20 Feb - Disclosure under Regulation 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 for Aditi C Bhanot & Virgo Advisors Pvt Ltd | [Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 20 Feb - Disclosure under Regulation 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 for Aditi C Bhanot & Virgo Advisors Pvt Ltd](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34E832AC_58AA_4958_B1C0_090492503A7C_105314.pdf) |
| 18 Mar - Uday Gurkar ceases April 1; Kishore Saletore appointed effective April 1, 2026, five-year term. | [Announcement under Regulation 30 (LODR)-Change in Directorate 18 Mar - Uday Gurkar ceases April 1; Kishore Saletore appointed effective April 1, 2026, five-year term.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15b21977-6159-4d89-94b5-9ea4d4360dd9.pdf) |
| 15h - Board seeks postal ballot approval for Kishore Saletore’s 5-year appointment from April 1, 2026. | [Announcement Under Regulation 30 - Postal Ballot 15h - Board seeks postal ballot approval for Kishore Saletore’s 5-year appointment from April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f4f9793e-9a46-4852-aec6-ee68b4880ae2.pdf) |
| 14h - FDC confirms it is not a large corporate; outstanding borrowings were nil as of March 31, 2026. | [Confirmation Regarding Company Not Falling Under Large Corporate Criteria As On March 31, 2026 14h - FDC confirms it is not a large corporate; outstanding borrowings were nil as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/65a24b1e-81b4-4461-ba61-933b2d54846a.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_FDC_2011_2012_11072012121551.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f883777c-ea48-419a-ae7f-8fa56e77856a.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44e9e558-8f82-4929-acbd-3f27f2f1fb69.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af599cac-85c4-49d9-8e82-a7b47c5a67e9.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/74935531599.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/71781531599.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/66842531599.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/5315990319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/5315990318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/531599/5315990317.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2023-11-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ecb9fe3-d93a-446e-9010-4738885b3477.pdf) |
| 2023-02-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf7867ab-6486-4960-b4c7-6e8b67dcc1e3.pdf) |
| 2022-11-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241e9c06-d5a0-4b4d-9437-9f4cb5be1bfa.pdf) |
| 2022-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbe476a2-b901-41dd-aea0-81a77af23101.pdf) |
| 2022-05-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=621f7f66-882e-4eca-87d5-4277be44266a.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2023-11-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c4bd23-f539-4ff2-ab33-911446335d86.pdf) |
| 2022-11-18 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6365f43-9c50-4e7b-aa84-45ceb98c2a55.pdf) |
| 2022-05-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=634caf49-31ae-4451-8bca-128de82df823.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6dc940c6-0bc5-488e-bf3f-b6e97419722d.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6dc940c6-0bc5-488e-bf3f-b6e97419722d.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2230e3b2-3403-4de2-a14f-66403e976d8b.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e97e2d9a-11db-45b0-ba25-1b4743afdb0e.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2230e3b2-3403-4de2-a14f-66403e976d8b.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e97e2d9a-11db-45b0-ba25-1b4743afdb0e.pdf) |
| Nov 2016 | [Concall - Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=BAE7D38B_ADCA_4C42_A9FF_E647F5F2099C_163129.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa73d93d-6b97-4e8b-ae0a-46a1a2c11159.pdf) |
| May 2016 | [Concall - May 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68F46EFF_EBFB_4F97_898D_E176BD299040_194327.pdf) |
| Jun 2017 | [Concall - Jun 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9fbf3a7-5d13-4828-a40e-c8cbd5a8df85.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2022-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa73d93d-6b97-4e8b-ae0a-46a1a2c11159.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:00.612Z.